Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion type Assertion NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_head.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion description "[In this study, though only a single cell line was used for the experiment and the data are limited, our results suggest that paclitaxel together with low-dose CPT-11 is a promising basis for a new combination cancer chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion evidence source_evidence_literature NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion SIO_000772 23504048 NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion wasDerivedFrom befree-20150227 NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.
- NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_assertion wasGeneratedBy ECO_0000203 NP926012.RACyZDDQmLoh_OncwQgf4FUHTk7ti2lSdkQzkIupAEZq0130_provenance.